Document Detail

Drugs in pregnancy--the issues for 2010.
MedLine Citation:
PMID:  21041865     Owner:  NLM     Status:  In-Process    
A Motherisk symposium on establishing benchmarks for the evaluation of medications during pregnancy, was held on May 10, 2006, under the auspices of the Canadian Society of Pharmacology and Therapeutics. From that symposium came a consensus on the need for collection and analysis of data on fetal safety and ongoing post-marketing surveillance, which in turn led to the establishment of CaseMed-Pregnancy--the Canadian Alliance for Safe and Effective Medication During Pregnancy and Breastfeeding.
Donald B Davis
Related Documents :
1985305 - Asthma and pregnancy. a challenge for everyone concerned.
15834875 - Preliminary study on the efficacy and safety of lamivudine and interferon alpha therapy...
17565615 - Prevalence and predictors of antidepressant use in a cohort of pregnant women.
17328645 - Drug treatment during pregnancy and isolated orofacial clefts in hungary.
22468575 - Effectiveness of group psychotherapy for adult outpatients traumatized by abuse, neglec...
16601595 - The risk of neuro-orthopaedic malformations following in-vitro fertilization.
Publication Detail:
Type:  Journal Article     Date:  2010-10-26
Journal Detail:
Title:  Journal of population therapeutics and clinical pharmacology = Journal de la thérapeutique des populations et de la pharamcologie clinique     Volume:  17     ISSN:  1710-6222     ISO Abbreviation:  J Popul Ther Clin Pharmacol     Publication Date:  2010  
Date Detail:
Created Date:  2010-11-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101530023     Medline TA:  J Popul Ther Clin Pharmacol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  e332-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cholinesterase inhibitors and the risk of pulmonary disorders in hospitalized dementia patients.
Next Document:  Medication Exposure in Pregnancy Risk Evaluation Program (MEPREP).